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Summary 
In the Drosophila CNS, both neurons and glia are de- 
rived from neuroblasts. We have identified a gene, 
glial cells missing (gcm), that encodes a novel nuclear 
protein expressed transiently in early glial cells. Its 
mutation causes presumptive glial cells to differenti- 
ate into neurons, whereas its ectopic expression 
forces virtually all CNS cells to become glial cells. 
Thus, gcm functions as a binary switch that turns on 
glial fate while inhibiting default neuronal fate of the 
neuroblasts and their progeny. Similar results are also 
obtained in the PNS. Analyses of the mutant revealed 
that "pioneer neurons" can find correct pathways with- 
out glial cells and that neurons and glia have a common 
molecular basis for individual identity. 
Introduction 
One of the major challenges in developmental biology is 
to understand how cellular diversity is created. A theoreti- 
cally possible mechanism would be to determine two cell 
fates by the presence or absence of a single switch mole- 
cule. The nature of such a gene was clearly foretold by 
Waddington (1940). To define such a switch molecule ex- 
perimentally, we require three pieces of evidence. First, 
the presence of the molecule is restricted to the cells that 
are to be "turned on." Second, in the absence of the mole- 
cule, all cells follow the "default" fate. Third, the ectopic 
presence of the molecule turns on all cells to the "alterna- 
tive" fate. Under these criteria, only a few molecules have 
been shown to act as binary switches in major cell fate 
decisions. Here we report our findings of an additional 
gene in this class in Drosophila, one which functions as 
a binary switch to determine whether cells in the nervous 
system follow one of the two differentiation pathways, neu- 
ronal or glial. 
The Drosophila nervous system is a highly sophisticated 
model system for developmental neurobiology, with its 
well-characterized anatomy and powerful genetic tech- 
niques (reviewed by Goodman and Doe, 1993). The neu- 
rogliogenesis of the embryonic central nervous system 
(CNS) begins in the neuroectoderm with the invagination 
of about 29 identified neuroblasts and one glioblast (the 
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longitudinal glioblast [LGB]) per hemisegment. The neuro- 
blasts generate several ganglion mother cells, each of 
which then divides to become two neurons. It was recently 
shown that some neuroblasts also produce glial cells. The 
neuroblast NBI-1 first generates two identified neurons, 
aCC and pCC. In abdominal segments, NBI-1 then gener- 
ates three glial cells, including the A and B glial cells plus 
a cluster of neurons, indicating that NBI-1 is a neuroglio- 
blast (Udolph et al., 1993). It is also strongly suggested that 
the abdominal N B6-4 divides symmetrically to produce the 
VUM support glial cell and a cell body gila (S. Higashijima 
et al., personal communication). In addition to these gila- 
producing neuroblasts, the LGB divides several times to 
produce six to eight glial cells that constitute majority of 
the longitudinal glial cells (Doe et al., 1988; Jacobs et al., 
1989; Goodman and Doe, 1993; Ito et al., 1995). The ori- 
gins of other glial cells are mostly unknown, but they are 
likely to be derived from the ectodermal neuroblasts. In 
addition to these ectodermal cells, the mesectodermal 
precursors generate midline gila and additional neurons. 
The mature em bryonic CNS consists of about 200 neurons 
and 24-28 ectodermal glial cells per hemisegment plus 
a small number of mesectodermal midline gila. Many neu- 
rons and most of the glial cells have been identified by 
their locations, morphology, and gene expression patterns 
(e.g., reviewed by Goodman and Doe, 1993; for glial map- 
pings and nomenclature, see also Kl&mbt and Goodman, 
1991 ; Ito et al., 1995). 
Extensive genetic analyses have identified a number of 
genes involved in cell fate specification in the CNS. Among 
them, several genes, including elav, pointed, and repo 
(also known as rk2), are expressed either in neurons or in 
glial cells exclusively and have functions in differentiation 
steps specific for the corresponding cell types (e.g., Rob- 
inow and White, 1988; Kl&mbt, 1993; Klaes et al., 1994; 
Xiong et al., 1994; Campbell et al., 1994; Halter et al., 
1995). However, none of the previously identified genes 
have been shown to be involved in neuronal/glial determi- 
nation. 
The mutant we isolated is named glial cells missing 
(gcm) based on the initial finding that ectodermal glial cells 
are entirely absent. The gcm gene encodes a novel nu- 
clear protein. First, we have shown that gcm is expressed 
exclusively in all ectodermal glial cells at the earliest 
stages. Second, in gcm loss-of-function mutant, the pre- 
sumptive glial cells differentiate into neurons. Third, under 
gcm ectopic expression, virtually all CNS cells differenti- 
ate into glial cells. These results indicate that gcm func- 
tions as a binary switch in neuronal/glial determination. 
We also obtained consistent results in the peripheral ner- 
vous system (PNS), showing glial/neuronal determination 
in the PNS is also governed by the gcm gene. 
We obtained further insights in differentiation and func- 
tions of glial cells by examining the gcm phenotype. We 
have shown that the "pioneer neurons" can find their cor- 
rect pathways independent of the presence of glial cells, 
while other follower axons show defects in fasciculation 
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Figure 1. The gcm Mutants Fail to Express the gcm Gene and Have 
Defects in the Embryonic Nervous System 
(A and B) The gcm mutants have defects in the formation ofaxonal 
tracts. Normal (A) and gcm' mutant (B) embryonic CNSs at stage 16 
were stained with MAb BP102, which is specific for CNS axons. In a 
normal embryo (A), BP102 stains the ladder-like CNS axon bundles. 
In a gcm 7 mutant (B), the longitudinal tracts have often much fewer 
axons. The transverse commissures are sometimes fuzzy. Anterior 
is up. 
(C and D) The gcm transcripts were not detected in the mutants. Nor- 
mal gcm~len~CyO heterozygous embryos (C) and gcm ~ homozygous 
mutant embryos (D) at early stage 11 were stained for gcm rnRNA by 
in situ hybridization. The transcripts were detected in CNS neurogenic 
regions in normal embryos (brown spots in [C]). Blue stripes in(C) are 
generated by the lacZ gene on the balancer chromosome, indicating 
heterozygosity. In contrast, gcm mRNA was not detected in gcm 7 mu- 
tants (D). Anterior is up, ventral to left. 
Scale bar is 10 p.m in (A) and (B) and 60 p.m in (C) and (D). 
and pathfinding in the mutant nervous system. We also 
found that the presumptive glial cells that had transformed 
into neurons in gcm mutants behave in a stereotyped and 
reproducible manner, suggesting that each individual glial 
cell is transformed to a neuron with unique characteristics. 
Thus, we would like to suggest that neurons and glial cells 
have a common molecular mechanism for the determina- 
tion of individual identity. 
During the preparation of our manuscript, we noticed 
that groups from the Bellen and Goodman laboratories 
had also identified the same gene. We have agreed to 
use the name glial  cells missing (gcm). These two groups 
present results essentially consistent with ours supporting 
validity of our conclusions (Kania et al., 1995; Jones et 
al., 1995 [this issue of Cell]). 
Results 
Isolation of gcm Mutants with Defects in the 
Embryonic Nervous System 
The mutant gcm was isolated in our enhancer detector 
screening designed to identify genes involved in cell fate 
determination in the embryonic CNS. We generated 100 
lethal strains by insertion of P elements carrying the en- 
hancer detector gene, lacZ. We screened these strains 
first for lacZ expression in the CNS to isolate candidate 
genes involved in CNS development. From these isolated 
strains, we screened for defects in CNS development by 
staining the axonal tracts with an antibody against horse- 
radish peroxidase (HRP), which stains all neuronal cell 
surfaces, including axons (Jan and Jan, 1982). The original 
gcm allele, gcm P, showed serious defects in the formation 
of CNS axonal tracts. In vivo excisions of the P element 
generated three revertants and 17 lethal alleles with varied 
severity in axonal phenotype, indicating that the gcm chro- 
mosome has no other lethal mutations and that the gcm 
gene is in the vicinity of the P element insertion. Among 
them, gcm I had the most severe axonal defects. The longi- 
tudinal tracts of this allele have much fewer axons than 
normal in approximately 40% of the hemisegments (com- 
pare Figure 1A with Figure 1B). The transverse commis- 
sures are sometimes fuzzy. The gcm locus was mapped 
to cytogenetic position 30C on the second chromosome by 
in situ hybridization to polytene chromosomes. The mutant 
did not complement the lethality of Df(2L)3OA;C, a chromo- 
some that has deficiency at 30A-30C (Lindsley and Zimm, 
1992). 
To clone the gcm gene, we first isolated a genomic frag- 
ment adjacent to the P element insertion from the mutant 
genomic library and then cloned the wild-type genomic 
DNA around it (Figure 2A). By in situ hybridization and by 
Northern blot analysis, we searched a 15 kb genomic DNA 
for sequences transcribed in the embryonic CNS. Both 
analyses detected only one transcription unit adjacent to 
the insertion point (Figure 2A). Screening of a cDNA library 
of an early embryonic stage using this region as a probe 
resulted in the isolation of several cDNA clones. The lon- 
gest clone was 2 kb, consistent with the results of Northern 
blot analysis. The 5' end of the cDNA was mapped 5 bp 
downstream of the insertion point (Figure 2A). Genomic 
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Figure 2. StructureofthegcmGeneandtheConceptuaIGcmProtein 
(A) Genomic map of gcm locus. About 12 kb of the genomic map 
near the P element insertion site is shown. The P element insertion 
is depicted by a triangle, with an arrow indicating the lacZ gene. Open 
and closed rectangles indicate the coding and noncoding regions of 
the gcm exons, respectively. The intron is 75 bp long. The deletion 
in gcm' is shown at the top. Restriction enzymes: B, BamHI; E, EcoRI; 
H, Hindlll. 
(B) Deduced amino acid sequence of gcm. The conceptual mino acid 
sequence ncoded by the gcm cDNA clone 9 is shown. The gcm cDNA 
is 1960 bp long with an open reading frame of 504 amino acids. The 
predicted amino acid sequence showed no significant homology with 
any known protein. It has two candidate methionines for the initiation 
codon (italicized). The nuclear targeting signal is indicated by double 
underlining. Single underlining indicates the basic cysteine-rich re- 
gion. The MPVP repeats and the PEST-like sequence are indicated 
by broken double underlining. The homopolymeric amino acid 
stretches are depicted by broken single underlining. 
(C) Characteristic features of the primary structure of the gcm protein. 
The N-terminal isto the left. The double and single underlining indicate 
the nuclear targeting sequence and the basic cysteine-rich region, 
respectively. Small ines in the upper and the lower half of the rectangle 
indicate basic and acidic residues, respectively. 
deletion in the gcm I chromosome is schematically shown 
in Figure 2A. 
By in situ hybridization to embryos, we examined 
whether gcm mutants express the isolated gene. In normal 
embryos heterozygous for gcm' and a balancer chromo- 
some, mRNA of the gene is detected in the CNS neuro- 
genic region (brown spots in Figure 1C), in addition to the 
blue stripes that are the reaction product generated by 
the lacZ gene on the balancer chromosome indicating het- 
erozygosity. In contrast, mRNA of the gene was not de- 
tected in homozygous gcm' embryos (Figure 1 D). We also 
found that embryos homozygous for gcm P express no de- 
tectable mRNA of the gene, although they have a slightly 
milder axonal phenotype than gcmt These results indicate 
that the isolated gene is gcm. 
Because these two alleles, gcm ~ and gcm p, express no 
detectable gcm mRNA, we used them for further pheno- 
type analysis. Since both alleles have intact gcm coding 
regions, we cannot exclude a possibility that these alleles 
express very small amount of normal gcm protein. 
The gcm Gene Encodes a Novel Nuclear Protein 
The 1960 bp gcm cDNA contains an open reading frame 
of 504 amino acids (Figure 2B). The predicted amino acid 
sequence of the gcm cDNA has a distinct nuclear targeting 
sequence, (KJR)2-Xlo-(K/R)3_s (Dingwall and Laskey, 1991), 
shown by double underlining in Figures 2B and 2C. Other 
than the nuclear targeting sequence, gcm showed no sig- 
nificant homology with any known proteins. Thus, gcm is 
most likely a nuclear protein of a novel class. 
One remarkable feature of the protein is that most basic 
residues are located in the N-terminal half, comprising 
several basic regions (Figure 2C). On the other hand, 
acidic residues are distributed evenly throughout he pro- 
tein (Figure 2C). Gcm has a highly basic cysteine-dch re- 
gion (single underlining in Figures 2B and 2C). Gcm also 
has one PEST-like sequence, which may function as a 
signal for rapid degradation (Rogers et al., 1986), and 
three repeats of a sequence MPVP in the N-terminal region 
(both indicated by broken double underlining in Figure 2B). 
Homopolymeric stretches of glutamine, serine, glycine, 
and tyrosine residues are found in the C-terminal half of 
the protein (broken single underlining in Figure 2B). The 
open reading frame has two candidate initiation methio- 
nines (italicized in Figure 2B), whose preceding nucleotide 
sequence matches the proposed translation initiation se- 
quence, (C/A)AA(A/C) (Cavener, 1987). The 3' untrans- 
lated region carries an mRNA instability motif, AUUUA 
(Shaw and Kamen, 1986). 
Expression of gcm in Glial Cells at Early Stages 
We investigated gcm expression by in situ hybridization 
to embryos. In the embryonic CNS, we found that the ex- 
pression of gcm mRNA is located in glial precursors and 
immature glial cells during a short period of gliogenesis. 
In the CNS, gcm mRNA is first detected in one cell per 
hemisegment at early stage 11 (Figure 3A; staging is ac- 
cording to Campos-Ortega and Hartenstein, 1985). This 
cell is the LGB, located in the most lateral position in the 
neurogenic region medial to the segmental furrow. At mid- 
stage 11, LGB divides symmetrically (thin arrowheads in 
Figure 3B); then, the progeny migrate medially. Two to 
three other cells per hemisegment express gcm mRNA 
at this stage. One is NB6-4 (closed arrows in Figure 3B), 
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Figure 3. Expression of gcm mRNA and the 
Enhancer Detector lecZ 
(A-C) gcm mRNA is expressed in the glial pre- 
cursors and in the immature glial cells. CNS 
neurogenic regions of normal embryos were 
stained for gcm mRNA by in situ hybridization. 
gcm rnRNA is first detected in the LGB in each 
hemisegment at early stage 11 (A). At mid- 
stage 11 (B), NB6-4 (closed arrow) and one ad- 
ditional cell (open arrow) start o express gcm. 
The thin arrowhead indicates the LGB, which 
has just divided symmetrically. At early stage 
12 (C), gcm mRNA is detected in the medially 
migrating VU M support glial cell (closed arrow), 
which is one of the progeny of NB6-4. Expres- 
sion pattern in other cells at this stage also 
matches that of developing lial cells. Through- 
out embryonic development, gcm mRNA is not 
detected in the midline region (thick arrow- 
heads in [A]-[C]), indicating gcm is not ex- 
pressed in midline gila. Small bars and thick 
arrowheads indicate segmental furrows and 
midline, respectively. Anterior is up. 
(D) gcm mRNA is also detected in the PNS 
neurogenic region of each segment at stage 
10. This expression disappears at the begin- 
ning of stage 11. Anterior is up, ventral to the 
left. 
(E) The enhancer detector lacZ is expressed 
in glial cells in the same pattern as gcmmRNA. 
Normal gcmPl+ heterozygous embryos at mid- 
stage 11 were stained with anti-lacZ antibody. 
At this stage, lacZ is detected in the progeny 
of the LGB, NB6-4, and in one additional cell 
per hemisegment (compare with [B]). 
(F) gcmPIgcm Pmutant embryos at mid-stage 11 were stained with anti-lacZ antibody. The number and locations of the lacZ-positive cells are 
almost identical to those in normal gcmPl+ heterozygous embryos (compare with [E]), indicating that the glial cell divisions are normal in the 
mutant• 
Small bars, thick and thin arrowheads, and closed and open arrows in (E) and (F) indicate the same as those in (A)-(C). Scale bar is 10 ~m in 
(A)-(C), (E), and (F) and 100 I~m in (D). 
judged by its location and behavior of the progeny. Just 
after it expresses gcm, NB6-4 divides symmetrically; then, 
one of the progeny, the presumptive VUM support glial 
cell, migrates medially, gcm mRNA is detected in the mi- 
grating presumptive VUM support glial cell (closed arrows 
in Figure 3C). The other one or two gcm-positive cells 
located around the anterior border of the segment (open 
arrow in Figure 3B) correspond to the immature glial cell(s) 
reported by Halter et al. (1995) (see Figure 4B in Halter 
et al., 1995). At early stage 12, gcm mRNA is detected in 
several other cells (see Figure 3C). Expression patterns 
in those cells match that of developing glial cells (Xiong 
et al., 1994; Campbell et el., 1994; Halter et al., 1995). The 
expression fades during stage 12 and is hardly detected 
at stage 13, when most of the glial cells have become 
postmitotic (Campbell et ai., 1994; Halter et al., 1995). 
We traced these gcm-positive cells to later develop- 
mental stages by marking them with the enhancer detector 
lacZ on the gcm p chromosome. The lacZ protein of the 
gcm p chromosome, diffuses into whole cell bodies to make 
entire cell morphology visible. We found that the gcmPl+ 
embryos express lacZ essentially in the same pattern as 
gcm mRNA (compare Figure 3E with Figure 3B), indicating 
that gcm-positive cells coexpress lacZ on the gcm p chro- 
mosome. Since lacZ protein is stable in Drosophila em- 
bryos, it is detected in virtually all the ectodermal glial cells 
at a later stage (Figure 4C). We could detect neither gcm 
mRNA nor lacZ expression in the midline region (large 
arrowheads in Figures 3A-3C and 3E), indicating that nei- 
ther is expressed in the midline glial cells, which are de- 
rived from the mesectoderm. These results indicate that 
gcm is expressed in all glial precursors and immature glial 
cells except those derived from the mesectoderm. 
In the brain neurogenic region, we also detected gcm 
mRNA expression during stage 11 (data not shown). In 
the larval brain, gcm enhancer trap lacZ is expressed in 
the optic lobe from late second instar to third instar (data 
not shown), when gliogenesis takes place (Winberg et al., 
1992). It is very likely that these gcm- or lacZ-positive cells 
in the brain are glial precursors and immature glial cells. 
At stage 10, gcm mRNA is detected in the PNS neuro- 
genic region of each segment (Figure 3D). This expression 
ceases at the beginning of stage 11. In gcmPl+ embryos, 
lacZ protein is detected in PNS neurogenic region in the 
same pattern as that of gcm mRNA. At later stages in the 
PNS, lacZ is detected in a subset of glial cells such as 
ligament cells of the chordotonal organ, support cells of 
dorsal bipolar dendritic cells, and peripheral glial cells 
(data not shown). 
Besides the neurogenic regions, gcm is also expressed 
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Figure 4. Mutant Glial Cells Differentiate into Neurons with Unique 
Individual Characteristics 
(A and B) gcm mutation disrupts glial differentiation. Normal (A) and 
gcm' homozygous mutant (B) embryos at stage 15 were stained with 
the anti-repo antibody• In normal embryos (A), the antibody stains 
nuclei of most of the glial cells, except midline gila. Only glial cells on 
the dorsal surface are visible in this focal plane• In gcm mutants (B), 
virtually no cells express repo. 
(C) In gcmPl+ normal heterozygous embryos, the lacZ-positive early 
glial cells differentiate into mature glial cells• gcmPl+ normal heterozy- 
gous embryos at early stage 14 were stained with anti-lacZ antibody. 
LacZ is detected in virtually all glial cells, except in midline gila. In 
this picture, only glial cells on the dorsal surface of the CNS are in 
focus. The array of longitudinal glial cells is visible• A and B glial cells 
are indicated as A and B, respectively• 
(D) In gcm mutant embryos, the lacZ-positive presumptive glial cells 
differentiate into neurons. The CNS of gcmPlgcm P mutant embryos at 
early stage 14 were stained with anti-lacZ antibody. The number of 
lacZ-positive cells is about 25 per hemisegment, about the same as 
that of normal ectodermal glial cells (24-28). These lacZ-positive cells 
migrate to positions different from the normal pattern (C), and most 
of them have a neuron-like round shape. We have confirmed that at 
least 21 of them send out axons, strongly suggesting that they have 
differentiated into neurons• Thelocation and axonal extension pattern 
of these lacZ-positive cells are highly stereotyped. In abdominal seg- 
ments, seven to nine round-shaped cells located lateral to the anterior 
commissure send out axons medially. These axons fasciculate with 
each other to form a thick bundle and cross the midline along the 
posterior edge of the anterior commissure (closed arrow). Four to six 
cells located posterolateral to the posterior commissure send out ax- 
ons anteromedially, which extend in the posterior commissure (open 
arrow). Six to eight cells located anterior of the anterior commissure 
send out axons posteromedially, which presumably join the anterior 
commissure (not in focus). At later stages, about four cells located 
medially (asterisk), just anterior to the anterior commissures, extend 
axons posteriorly (axons are not visible at this stage). In thoracic seg- 
ments, the anterior commissure has two bundles of lacZ-positive axons 
in the most anterior region of the presumptive mesoderm 
beginning at the cellular blastoderm stage (data not 
shown). Expression of gcm in this region fades during 
stage 11. 
Mutation of gcm Transforms CNS Glial Cells 
into Neurons 
Since the expression pattern suggested an involvement 
of gcm in early glial differentiation, we first investigated 
glial cell divisions in the mutant. We used lacZ protein 
produced by the gem P chromosome to visualize glial cells 
in the mutant. In the gcmPlgcm p mutant embryos, in which 
gcm mRNA expression is hardly detectable, the initial lacZ 
pattern is almost normal (compare Figure 3F with 3El. The 
final number of lacZ-positive cells is about 25, almost the 
same as that of normal ectodermal glial cells (24-28). Until 
early stage 12, the locations of these lacZ-positive cells in 
the mutant are very similar to the locations of lacZ-positive 
glial cells in normal gcmPl+ embryos. Thus, in gem mu- 
tants, the initial divisions of the presumptive glial cells are 
essentially normal, and these cells express the enhancer 
detector lacZ as in normal embryos. 
To examine differentiation of mutant glial cells, we stud- 
ied expression of a glial-specific protein, repo. Repo is a 
homeodomain protein, required for glial differentiation, 
that is expressed in all CNS glial cells except in the mesec- 
todermal midline gila (Xiong et al., 1994; Campbel l  et al., 
1994; Halter et al., 1995). Repo expression begins at early 
stage 11 in the glial progenitors and immature glial cells 
and then lasts to the end of embryonic development.  Fig- 
ures 4A and 4B show photographs of late embryos stained 
with anti-repo antibody. In normal embryos, most of the 
glial cells except the midline gila express repo (Figure 4A). 
In gcm ~ embryos, virtually no cells express repo (Figure 
4B). In gcmPlgcm p mutant embryos, only a few of the lacZ- 
positive cells express repo in each hemisegment.  This 
leakage expression is rather stochastic, but it is apparently 
all or none. The mutant glial cells do not express repo 
even at earlier stages. On the other hand, gcm mRNA 
expression is normal in repo 3 mutant, a putative null allele 
of repo (Xiong et al., 1994; Halter et al., 1995), indicating 
that gcm is epistatic to repo (data not shown). We also 
examined expression of a putative transcription factor pro- 
tein, prospero (pros). In normal embryos, pros is ex- 
pressed in a subset of neurons and a subset of glial cells, 
including the longitudinal gila (Doe et al., 1991). In gcm 1 
embryos, pros expression in neurons is almost normal, 
whereas its expression in glial cells is absent (data not 
shown). 
We further investigated the fate of the mutant glial cells. 
In normal gcm~l+ embryos, the lacZ-positive presumptive 
(arrowhead). Two lacZ-positive cells in a medial region of the thoracic 
segments (circle) send out axons posterolaterally (slightly out of ocus). 
These two axons do not fasciculate with each other. 
Small bars in (C) and (D) indicate the segmental boundaries. One 
thoracic segment (T3) and four abdominal segments (A1-A4) are 
shown. Anterior is up. Scale bar is 30 ~m in (A) and (B) and 20 p.m 
in (C) and (D). 
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Figure 5. gcm Mutation Transforms Glial Cells to Neurons in the PNS 
(A and B) gcm mutation disrupts repo expression in the PNS glial cells. 
The PNSs of normal (A) and gcm ~ mutant (B) embryos were stained 
with anti-repo antibody. In the normal PNS (A), repo is expressed in 
several glial cells, such as in ligament cells of the chordotonal organ 
(open arrowhead), the support cell of dorsal bipolar dendritic cell (aster- 
isk), and PC3 (circle), one of the peripheral glial cells. Repo expression 
in these cells is not detected in the gcm mutant (B). 
(C and D) The mutant ligament cells have neuron-like morphology• 
Nuclei of all PNS cells in normal (C) and in gcm ~ mutant (D) embryos 
were stained with the antibody against cpo. In normal embryos (C), 
five round-shaped nuclei of neurons (closed arrow) and five thin nuclei 
of ligament cells (open arrowhead) are stained in two rows in the ventral 
half of the chordotonal organ• I  gcm mutants (D), there are 10round 
cells (open arrow) at the ventral part of the chordotonal organ, indicat- 
ing that the mutant ligament cells have a neuron-like shape. 
(E and F) The gcm mutants have an increased number of neurons in 
the chordotonal organ. Normal (E) and gcm I mutant (F) embryos were 
stained with the antibody against a neuron-specific protein, elav. I  
glial cells differentiate into mature glial cells (Figure 4C). 
In gcmPIgcm P mutant embryos, the lacZ-positive presump- 
tive glial cells fail to migrate to normal positions (Figure 
4D). Their cell bodies have a round shape typical of neu- 
rons. We found that most of these lacZ-positive cells send 
out axons. At stage 14, lacZ-positive axon bundles running 
across the midline are visible in every segment (open and 
closed arrows and arrowhead in Figure 4D). This axonal 
lacZ expression is not simply caused by the increase of 
lacZ gene dosage in gcmPIgcm P, because the same results 
were obtained with embryos heterozygous for gcm p and 
gcm 1, the latter of which express no detectable lacZ. 
By examining a number of hemisegments, we obtained 
the following results. First, the number of lacZ-positive 
cells in the mutant is about 25 per hemisegment, almost 
the same as that of the normal ectodermal glial cells (24- 
28). Second, at least 21 lacZ-positive cells send out axons. 
Third, the axonal extension pattern is highly stereotyped 
and reproducible, not only from individual to individual, but 
from segment to segment, with minor differences between 
thoracic and abdominal segments (Figure 4D; see the leg- 
end for details). Thus, it is strongly suggested that in gcm 
mutants the lacZ-positive presumptive glial cells differenti- 
ate into neurons with unique characteristics. 
The gcm mutants also show general phenotype com- 
mon to glial mutants. Normal CNS neuromere shortens 
at the end of the embryonic development, whereas the 
mutant CNS remains elongated (data not shown). This 
condensation defect has also been seen in other mutants 
with glial defects, such as pros  and repo (Doe et al., 1991; 
Xiong et al., 1994; Campbell et al., 1994; Halter et al., 
1995). The contour of the mutant neuromere is irregular 
compared with normal embryos (Figures 4A and 4B). The 
repo mutant shows a similar phenotype (Halter et al., 
1995). 
The mesectodermal midline gila express neither gcm 
nor repo. We investigated their cell fate using an enhancer 
trap strain AA142, which expresses lacZ in midline gila 
(Kl&mbt et al., 1991). AA142 stained normal number of 
cells in gcm ~ background, indicating that gcm mutation 
does not affect midline gila (data not shown). 
Mutation of gcm Transforms PNS Glial Cells 
into Neurons 
In the normal PNS, repo is expressed in gcm-pos i t ive  glial 
cells: the ligament cells of the lateral pentascolopidial 
chordotonal organ (LCH5), the support cells of the dorsal 
bipolar dendritic cell, and the peripheral glial cells (Figure 
5A; Xiong et al., 1994; Campbell et al., 1994; Halter et al., 
1995). In gcm mutants, repo expression in these PNS glial 
cells is not detected (Figure 5B), indicating gcm is required 
for differentiation of these cells. 
normal embryos (E), elav is expressed in five neurons (closed arrow), 
while ligament cells do not express elav. In gcm I embryos, elav- 
positive cells increase in 15% of the chordotonal organs examined, 
indicating an increase in neurons• (F) shows an extreme case with 10 
elav-positive cells (open arrow). 
All embryos are at stage 16. Anterior is left, dorsal up. Scale bar, 
10 ixm. 
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A B C D Figure 6. Ectopic Expression of gcm Pro- motes Glial Differentiation While Inhibiting 
Neuronal Differentiation 
Ectopic expression of gcm in the CNS was per- 
formed by generating scaGAL; UAS-gcm em- 
bryos. 
(A) The CNS of an embryo with gcm ectopic 
expression, stained with anti-repo antibody. 
Under gcm ectopic expression, 80%-90% of 
the CNS cells express repo (compare with a 
normal embryo, shown in Figure 4A). The total 
number of the CNS cells is not significantly al- 
tered. Most of these repo-positive ceils have 
elongated or irregular morphology t pical of 
glial ceils. Only t0%-20% of the CNS cells are 
repo negative and have a neuron-like round 
shape. 
(B and C) CNS of a normal embryo (B) and an 
embryo with gcm ectopic expression (C), stained with an antibody against a neuron-specific protein, elav. In normal embryos, all neurons, about 
200 per hemisegment, express elav (B). Under gcm ectopic expression, the number of elav-positive c lls is dramatically reduced to 10-30 per 
hemisegment (C). Most of the elav.negative c lls in (C) have a gila-like elongated or irregular shape, whereas all the elav-positive c lls in (C) have 
a neuron-like round shape. 
(D) CNS axons of an embryo with gcm ectopic expression was stained with BP102 antibody. The number of axons are much reduced compared 
with a normal embryo (shown in Figure 1A). 
All embryos are at stage 15. Anterior is up. Scale bar, 30 I~m. 
We further investigated fate of the ligament cells. The 
LCH5 is comprised of five chordotonal organs. Each 
chordotonal organ is comprised of one neuron and three 
glial cells: the ligament cell, cap cell, and scolopale. These 
four cells are derived from a single sensory organ precur- 
sor (Bodmer et al., 1989). We stained all cell nuclei of 
the PNS with an antibody against the couch potato (cpo) 
protein (Bellen et al., 1992). In normal embryos, five round- 
shaped nuclei of neurons (closed arrow in Figure 5C) and 
five thin-shaped nuclei of ligament cells (arrowhead in 
Figure 5C) are stained in two rows in the ventral half of 
the chordotonal organ. In gcm mutants, 10 round cells 
are visible at the ventral part of the chordotonal organ 
(open arrow in Figure 5D), indicating that the mutant liga- 
ment cells are transformed to cells indistinguishable from 
neurons. 
In normal LCH5, the five neurons express a neuron- 
specific protein, elav (Figure 5E; Robinow and White, 
1988). In gcm ~ embryos, 15% (7 of 48) of chordotonal 
organs showed increase in elav-positive cells. Figure 5F 
shows an extreme case in which 10 elav-positive cells 
are visible, indicating that all the five ligament cells are 
transformed into elav-positive neurons. These results indi- 
cate that gcm mutation transforms repo-positive glial cells 
to neurons in the PNS as well as in the CNS. 
Ectopic Expression of gem Transforms Neurons 
into Glial Cells 
To investigate the effect of gcm ectopic expression in neu- 
ronal cells, we used the GAL4-UAS system (Brand and 
Perrimon, 1993). The gcm cDNA was subcloned into the 
polycloning site of the pUAST vector and was then intro- 
duced into flies by germline transformation to establish 
UAS-gcm flies. The UAS-gcm flies were crossed to the 
scaGAL strain (Klaes et al., 1994), which carries a 
transgenic GAL4 gene driven by the promoter of a neuro- 
genic gene, scabrous (sca) (Mlodzik et al., 1990). In sca- 
GAL; UAS-gcm embryos, GAL4 protein is expressed in 
all the neuroblasts and their progeny (Klaes et al., 1994) 
and then binds to the upstream activation sequences 
(UASs) in the pUAST vector to activate the recombinant 
gcm gene. 
We first found that in these scaGAL; UAS-gcm embryos, 
all the neuroblasts become repo positive (data not shown). 
At stage 15, approximately 800-90% of CNS cells ex- 
press repo (Figure 6A; compare with a normal embryo 
shown in Figure 4A). Most of these repo-positive cells have 
elongated or irregular cell shapes typical of glial cells (e.g., 
Ito et al., 1995). Only 100-20% of the CNS cells are repo 
negative, and as far as we could examine, all ofthem have 
round shapes typical of neurons. Thus, the number of glial 
cells increases ignificantly under gcm ectopic expression. 
We further investigated expression of a neuron-specific 
protein, elav. In normal embryos, all neurons, about 200 
per hemisegment, express elav (Figure 6B; Robinow and 
White, 1988), whereas glial cells do not (Xiong et al., 1994; 
Campbell et al., 1994). Under gcm ectopic expression, 
only 10-30 cells per hemisegment, about 5%-15% of the 
normal number, are elav positive (Figure 6C). Thus, the 
number of elav-positive cells is reduced by 85%-95%. 
Most of the elav-negative cells have gila-like elongated or 
irregular shapes, whereas all the elav-positive cells have 
neuron-like round shapes. Embryos with gcm ectopic ex- 
pression have much fewer axons (Figure 6D) compared 
with normal embryos (see Figure 1A). Those remaining 
neurons in embryos with gcm ectopic expression (Figure 
6C and 6D) are likely those that have divided and ifferenti- 
ated before effective amount of gcm has accumulated. 
Because gcm ectopic expression do not significantly 
alter the total number of CNS cells, the increase of glial 
cells must be at the expense of neurons. Thus, gcm ec- 
topic expression inhibits neuronal differentiation while pro- 
moting glial differentiation. 
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Figure 7. Pioneer Neurons Can Find Correct Pathways in the gcm 
Mutant, Whereas Other Follower Axons Have Serious Defects in Tract 
Formation 
Normal (A and C) and gcm' mutant (B and D) embryos at early stage 
13 (A and B) and stage 16 (C and D) were stained with anti-fasciclin 
II antibody. 
(A and B) In stage 13 normal embryos (A), the anti-fasciclin II a tibody 
stains anteriorly extending pCC axons (arrows in [A]) and laterally 
extending aCC axons (arrowheads in [A]), which pioneer the longitudi- 
nal pathway and the intersegmental nerve, respectively. In gcm 7 mu- 
tants (B), axons of these pioneer neurons appear normal in most seg- 
ments, indicating that they can find their correct pathway without the 
help of glial cells. 
(C and D) The gcm mutants show defects in axonal tract formation at 
late embryonic stages. At stage 16, when CNS development is almost 
complete, the anti-fasciclin II antibody stains three discrete bundles in 
the longitudinal connectives (C).The pCC axons are in the medial-most 
MP1 pathway. In gcm mutants (D), the three fasciclin II-positive bun- 
dles are often interrupted and ppear defasciculated. The second me- 
dial-most FN3 pathway often show misroutings to lateral directions 
(open arrows in [D]). In normal embryos, axons of the motoneurons 
exit CNS in two nerve bundles, segmental nerve (closed arrow in [C]), 
and intersegmental nerve (arrowhead in [C]).These two nerves nor- 
mally make contact a  the border of CNS (exit junction; asterisk in 
[C]). In gcm mutant embryos (D), almost normal number of axons leave 
the longitudinal tracts. But they often exit the longitudinal tracts t
abnormal positions inmany thin bundles (open circles in [D]) or in one 
thick bundle (closed circle in [D]). Even when two nerves are formed, 
Pioneer Neurons Can Find Correct Pathways 
in gcm Mutant 
In the Drosophila CNS, many glial cells are associated 
with axons and have been implicated to function in axonal 
guidance (e.g., reviewed by Goodman and Doe, 1993). 
To elucidate glial functions in axonal tract formation, we 
investigated axonal behavior in gcm mutant. The longitudi- 
nal glial cells have been proposed to have functions in 
guiding the pioneer neurons, which extend the first axons 
in the longitudinal pathway (e.g., Jacobs and Goodman, 
1989; Jacobs, 1993; also reviewed by Goodman and Doe, 
1993). We investigated axonal behavior of pioneer neu- 
rons using the anti-fasciclin II antibody (G. Helt and C. S. 
Goodman, personal communication). At early stage 13 in 
normal embryos, the anteriorly extending axon of a fas- 
ciclin II-positive pioneer neuron, pCC, reaches the adja- 
cent anterior segment (arrows in Figure 7A). Slightly later, 
the MP1 neuron, another fasciclin II-positive pioneer neu- 
ron, extends its descending axon in the longitudinal path- 
way (data not shown). In gcm mutants, longitudinal glial 
cells do not exist since the lacZ-positive presumptive glial 
cells (see Figure 3F) fail to migrate to form the longitudinal 
array (see Figure 4D). However, pCC axons reach the next 
segments in most cases (arrows in Figure 7B). The MP1 
neurons also extend their axons normally slightly later than 
the pCC axons (data not shown). Thus, these pioneer neu- 
rons can find their correct pathways even in the absence 
of the longitudinal glial cells. 
Since insect glial cells have also been implicated for 
motor nerve formation (Bastiani and Goodman, 1986; also 
reviewed by Goodman and Doe, 1993), we investigated 
the behavior of the axons that pioneer motor nerves. In 
a normal embryo, axons of the motoneurons exit CNS in 
two nerves, the segmental nerve (arrow in Figure 7C) and 
the intersegmental nerve (arrowhead in Figure 7C). The 
anti-fasciclin II antibody stains many of the motor axons, 
including the axons of the aCC neurons, which pioneer 
the intersegmental nerve (arrowheads in Figure 7A). We 
found that the aCC axons extend almost normally in the 
mutant (arrowheads in Figure 7B), indicating they can find 
their correct pathway without glial cells. 
Although pathfindings of the pioneer neurons appear 
normal, gcm mutants have serious defects in axonal tract 
formation at later stages. At stage 16, when CNS develop- 
ment is almost complete, the anti-fasciclin II antibody 
stains two to three discrete bundles in the longitudinal 
connectives (Figure 7C). The pCC axons are included in 
the most medial MP1 pathway. In the gcm mutant, the 
fasciclin II-positive bundles are often interrupted and ap- 
pear defasciculated (Figure 7D). The second medial-most 
FN3 pathway often show misroutings to lateral directions 
(open arrows in Figure 7D). 
The gcm mutants also show defects in the formation of 
motor nerves. In gcm mutant embryos (Figure 7D), almost 
they fail to make contact at the correct position and go up the body 
wall independently (closed arrow and arrowhead in [D]). 
Anterior is up. Scale bar is 20 I~m in (A) and (B) and 30 ~Lm in (C) 
and (D). 
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normal number of axons leave the longitudinal tracts. But 
they often exit the longitudinal tracts at abnormal positions 
as many thin bundles (open circles in Figure 7D) or as 
only one thick bundle(closed circle in Figure 7D). In normal 
embryos, the segmental nerve and the intersegmental 
nerve make a contact at the margin of the neuromere (exit 
junction; asterisk in Figure 7C). In gcm mutants, even 
when two nerves are formed, they often do not make a 
contact; instead, they go up the body wall independently 
(arrow and open arrowhead in Figure 7D). Even with these 
abnormalities, almost the same number of axons finally 
leave the CNS and go up the lateral body wall as in normal 
embryos. 
Discussion 
Gcm Functions as a Binary Switch between 
Neuronal and Glial Determination 
We have isolated a Drosophila mutant, gcm, that showed 
serious defects in axon bundle formation. The isolation 
and sequencing of gcm cDNA revealed that gcm encodes 
a novel protein with a distinct nuclear targeting signal. We 
showed that gcm is expressed transiently in all glial cells 
except in the mesectodermal midline gila. Expression of 
gcm mRNA coincides closely with gliogenesis as it begins 
at early stage 11 and then fades during stage 12. 
We investigated glial cell fate in the mutant using the 
enhancer detector gene lacZ on the gcm p mutant chromo- 
some, which is expressed in the glial cells in normal het- 
erozygous embryos. In homozygous mutant embryos, the 
number and initial locations of the lacZ-positive cells are 
normal, indicating glial cell divisions are almost normal. 
But most of these mutant glial cells fail to express a gila- 
specific protein, repo, indicating that they have defects in 
glial differentiation. They also show defects in cell migra- 
tion. To our surprise, these mutant cells begin to send out 
axons in a stereotyped manner. These results strongly 
suggest that in gcm mutants, presumptive glial cells differ- 
entiate into neurons. 
We investigated the effect of gcm ectopic expression 
in the CNS using the GAL4-UAS system that is driven by 
the sca gene promoter. Under gcm ectopic expression, 
most of the CN S cells became repo positive, while number 
of elav-positive neurons decreased at least by 85% with 
concomitant reduction of axons. Thus, gcm ectopic ex- 
pression promotes glial differentiation while inhibiting neu- 
ronal differentiation. 
From these results, we conclude that glial/neuronal de- 
termination in Drosophila is governed by a single mole- 
cule, gcm. All CNS cells are originally bipotential so that 
they can differentiate into both neurons and glial cells, with 
neuronal differentiation as a default. They differentiate into 
neurons when gcm is absent, while they differentiate into 
glial cells when gcm is present. 
Under gcm ectopic expression, most CNS cells differen- 
tiate into glial cells. We consider that virtually no cells have 
intermediate characteristics between neurons and gila 
from the following reasons. First, cells negative for both 
elav and repo must be very small in number, if there are 
any at all, since repo-negative cells are only 100--20% 
in number, and they all have neuron-like round shapes, 
whereas most of elav-negative cells have gila-like mor- 
phology. Second, similarly, cells positive for both elav and 
repo must be very small in number, if there are any at all, 
since elav-positive cells are only 5%-15% in number, and 
they all have neuron-like round shapes, whereas most of 
repo-positive cells have gila-like morphology. These re- 
sults strongly suggest that gcm essentially functions in an 
all-or-none manner. Thus, we propose that gcm acts as 
a binary switch in neuronal/glial determination. 
Differentiation of Individual Glial Cells 
Once determined to either a neuronal or glial fate, each 
cell differentiates into a cell with unique individual charac- 
teristics, e.g., cell shape, location, or axonal extension 
pattern. In gcm mutants, presumptive glial cells differenti- 
ate into neurons. By examining the behavior of more than 
21 cells among 25 transformed cells per hemisegment, 
we conclude that patterns of their cell migration, axonal 
extension, and fasciculation are highly reproducible not 
only from individual to individual, but also from segment 
to segment with minor difference between thoracic and 
abdominal segments. This indicates that each individual 
glial cell is transformed into a neuron with unique charac- 
teristics. This can be explained by assuming that mecha- 
nisms that specify glial identity can also control cellular 
characteristics under abnormal differentiation into neu- 
rons. Thus, we would like to suggest that neurons and 
glial cells share a common molecular mechanism for their 
identity determ ination and th at this mechanism is indepen- 
dent of glial/neuronal determination mediated by gcm. 
Several genes, such as orthodenticle (otd), fushi tarazu 
(ftz), and pros, are expressed in the subsets of both neu- 
rons and glial cells and are required for their development 
(Finkelstein et al., 1990; Doe et al., 1988, 1991). These 
genes are good candidates for the components of such 
a common identity determination mechanism. This mech- 
anism may also be shared by m uscles, since several mole- 
cules are expressed in specific subsets of both neurons 
and muscles to determine their specific interactions 
(Chiba et al., 1995; Nose et al., 1994). 
In the PNS, we obtained results highly consistent with 
those in the CNS. The two genes gcm and repo are ex- 
pressed in the same PNS glial cells, such as ligament 
cells, the support cells of dorsal bipolar dendritic cell, and 
peripheral glial cells (Xiong et al., 1994; Campbell et al., 
1994; Halter et al., 1995; this paper). In gcm mutants, 
repo expression in these cells is not detected. The mutant 
ligament cells have round shapes typical of neurons, and 
they often express a neuron-specific protein, elav, indicat- 
ing their transformation into neurons. These results indi- 
cate that gcm also controls neuronai/glial determination 
in the PNS in a similar manner as in the CNS. 
In the chordotonal organ, gcm is expressed in the liga- 
ment cells, but is not expressed in the other two glial cells, 
the cap cell and the scolopale. Thus, cell fate determina- 
tion of these cells must depend on other molecules. A 
gene called sanpodo is shown to be involved in the deter- 
mination between scolopale and neuron (Salzberg et al., 
1994). In the chordotonal organ, gcm most likely functions 
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in neuronal/glial decision or glial identity specifications (or 
both) in combination with other genes. Involvement of 
other genes in neuronal/glial decision may explain the 
lower frequency of gila-to-neuron transformation i the mu- 
tant PNS than in the CNS. 
Among glial cells in the CN S, midline glial cells are differ- 
ent from other glial cells in many aspects. They are derived 
from mesectoderm and express neither gcm nor repo. In 
gcm mutants, midline glial cells appear normal, indicating 
gcm is not essential for their development. Thus, the mes- 
ectoderm-derived cells have different mechanisms for 
neuronal/glial determination, which is independent of 
gcm. This mechanism may be controlled, at least partly, 
by a segmentation gene engrailed(en), since en is required 
for correct glial/neuronal determination in grasshopper 
midline cells (Condron et al., 1994). 
At the postembryonic stage, we detected the expression 
of gcm enhancer detector lacZ in the larval optic lobe pri- 
mordia, suggesting that gcm also functions in gliogenesis 
in the larval brain. Gcm may also function in glial/neuronal 
determination in the adult PNS, since neurogenesis and 
gliogenesis appear to be coupled in the wing discs (Gian- 
grande et al., 1993; Giangrande, 1994). 
Glial Functions in Axonal Tract Formation 
In the Drosophila CNS, many glial cells are associated 
with axon bundles and have been implicated to be involved 
in nerve tract formation (e.g., reviewed by Goodman and 
Doe, 1993). In particular, the longitudinal glial cells have 
been considered to be important for axonal extension and 
guidance, since the pioneer neurons extend along them 
(Jacobs and Goodman, 1989). However, we have shown 
that pCC and MP1 pioneer neurons extend their axons 
apparently normally in the longitudinal direction in gcm 
mutants. Thus, some guidance mechanisms other than 
the longitudinal glial cells must lead these pioneer neurons 
to the correct longitudinal pathway. Glial cells have also 
been considered to be required for the pathfinding of moto- 
neurons (Bastiani and Goodman, 1986). However, in gcm 
mutants, the pioneer axons for the intersegmental nerve 
leave the CNS apparently normally and then extend to the 
lateral direction. At later stages, almost normal numbers 
of axons leave the CNS to go up the lateral body wall. 
Therefore, it is strongly suggested that some guidance 
mechanisms other than glial cells lead these motoneurons 
to the lateral direction. 
Although pioneer neurons behave apparently normally, 
the mutant shows serious axonal defects at later stages. 
Both CNS axonal tracts and motor nerves show defascicu- 
lation and misroutings. These results suggest that al- 
though glial cells are dispensable for the early pathfinding 
of a small number of pioneer neurons, they have essential 
supportive functions in the correct tract formation of the 
majority of axons. Since these nerve tracts are associated 
with a number of glial cells in normal embryos, their defects 
in the mutants can be caused by loss of pathfinding cues 
or extension support supplied by the glial cells. On the 
other hand, the axonal defects can also be caused by the 
secondary abnormality in neurons, since glial cells have 
functions in development and maintenance of 
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anti-I~-galactosidase (1:1000; Cappel), anti-elav antibody 9F8A9 (1:5; 
O'Neill et al., 1994), anti-cpo antibody (1:100; Bellen et al., 1992), 
anti-fasciclin II antibody MAb 1 D4 (1:100; generated by G. Helt in the 
Goodman laboratory). 
Molecular Cloning 
All procedures for molecular cloning were essentially according to the 
standard protocols (Sambrook et al., 1989). For in situ hybridization 
to polytene chromosomes, see Masai et al. (1993) and references 
therein. 
Genomic libraries of the CS strain and the gcmP/CyO strain were 
constructed with the ZFIXII kit (Stratagene). From the library of gcm~/ 
CyO strain, a genomic DNA fragment adjacent to the insertion point 
of the P element was obtained using the 5' half of the/acZ gene as 
a probe. This fragment was used to screen the wild-type genomic 
library to obtain several clones, spanning the 20 kb around the P 
element insertion. They were digested with Hindlll or Xbal to be sub- 
cloned into the polycloning site of a plasmid vector pBluescript II SK(-) 
(Stratagene). These clones were further divided by digestion and used 
as probes to test embryonic expression both by Northern blot analysis 
and in situ hybridization. Both analysis detected only one transcription 
unit adjacent to the P element insertion. This region was used as a 
probe to screen 2 × 10 s pfu of an embryonic cDNA library (3-12 hr 
AEL; made in Kornberg laboratory) to obtain 11 clones. One genomic 
clone and the two longest cDNA clones, clone 1 and clone 9, were 
sequenced in both directions using the Exolll deletion procedure and 
Sequenase II kit (U. S. Biochemicals). Homology search was carried 
out with the FASTA program (Pearson and Lipman, 1988) in GenBank. 
In Situ Hybridization to Embryos 
In situ hybridization with digoxigenin-labeled antisense RNA probes 
was done essentially as described by Masai et al. (1993). Genomic 
DNA fragments and cDNA clones were subclonad into pBluescript II 
SK(-) (Stratagene) and then used as templates for RNA probe produc- 
tion using the DIG-RNA labeling kit (Boehringer Mann heim). For mRNA 
expression assay in the mutant, eggs of gcmVen~CyO flies were col- 
lected and stained for lacZ activity as described by Kl~mbt et al. (1991). 
Embryos were then devitellinated and subjected to further steps o1 
in situ hybridization. Mutant homozygous embryos (gcml/gcm ') were 
distinguished from embryos with balancers (gcmVen'CyO, en~lCyO/ 
en'~CyO) by the absence of/acZ expression. 
Ectopic Expression Using the GAL4-UAS System 
The gcm gene was ectopically expressed in all the embryonic neuro- 
blasts and their progeny using the GAL4-UAS system (Brand and 
Perrimon, 1993). The MluI-Aflll fragment of gcm cD NA clone 9, which 
contains the entire coding region plus about 100 bp of 5' and 200 bp 
of 3' untranslated regions, was blunt-ended and inserted into the blunt- 
ended EcoRI site of the pUAST vector to form the P[UAS-gcm] con- 
struct. This construct was introduced into white flies by germline trans- 
formation according to the standard protocol (Spradling, 1986) to 
establish six UAS-gcm lines. These lines were either balanced or 
made homozygous and then crossed to scaGAL lines (Klaes et al., 
1994). 
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